PACIFIC EDGE LIMITED Pacific Edge Limited announced the appointment of Darrell Morgan as Chief Operating Officer. Darrell has extensive experience in senior leadership and executive roles in large, mid-sized and virtual pharmaceutical companies in the UK, Europe and New Zealand. He has more than 37 years' experience in pharmaceutical R&D, immunodiagnostics and device development for drug delivery across human and animal health, in R&D, technical operations and customer-facing roles.
As Chief Operating Officer, Darrell will be a key leader in the Dunedin office, and responsible for Pacific Edge's global laboratory operations, manufacturing, logistics, inventory management, the quality and regulatory compliance functions and operationalizing people and culture initiatives. He will have a focus on project management, people and culture, and operational excellence to optimize effectiveness, efficiency and on time delivery of products and services. Darrell will join Pacific Edge on 3 October 2022 and report to Chief Executive Dr. Peter Meintjes as a member of the C-Suite team.
He will be based in Dunedin. Since 2013, Darrell has been a senior leader with animal health company Argenta Research where his roles have included Global Head of Pharmaceutical Sciences, VP Customer Relationships - Pharmaceutical Sciences, and Product Development Director - Technical Operations. Prior to Argenta Research, he worked for global biopharmaceutical company UCB in the UK for eight years in senior roles with a focus on sterile drug product and medical device development.
Darrell is a chartered biologist, with post graduate diplomas in industrial pharmaceutical sciences and management, people and change.
